GregoryJGoresMD

PubMed

• Manuscript best practices: Takeaways from a community conversation.
  Carmen Chak-Lui Wong, Elliot B Tapper, Harmeet Malhi, Gregory J Gores> ;Hepatology. 2024 Mar 11
• Syngeneic Murine Models with Distinct Immune Microenvironments Represent Subsets of Human Intrahepatic Cholangiocarcinoma.
  Jennifer L Tomlinson, Binbin Li, Jingchun Yang, Emilien Loeuillard, Hannah E Stumpf, Hendrien Kuipers, Ryan Watkins, Danielle M Carlson, Jessica Willhite, Daniel R O'B...> ;Journal of Hepatology. 2024 Mar 6
• A small molecule MST1/2 inhibitor accelerates murine liver regeneration with improved survival in models of steatohepatitis.
  Ryan Watkins, Ana Gamo, Seung Hyuk Choi, Manoj Kumar, EeeLN Buckarma, Chantal McCabe, Jennifer Tomlinson, David Pereya, Blaz Lupse, Shirin Geravandi, Nathan W Wernebur...> ;PNAS Nexus. 2024 Mar 1
• PTEN Deficiency Induces an Extrahepatic Cholangitis-Cholangiocarcinoma Continuum via Aurora kinase A in Mice.
  Yang, Y., Wang, J., Wan, J., Cheng, Q., Cheng, Z., Zhou, X., Wang, O., Shi, K., Wang, L., Wang, B., Zhu, X., Chen, J., Feng, D., Liu, Y., Jahan-Mihan, Y., Haddock, A.,...> ;Journal of Hepatology. 2024 Feb 28
• Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) deletion in myeloid cells augments cholestatic liver injury.
  Ozturk, B., Ozturk, B., Anuradha Krishnan, Nazli Begum Ozturk, Kaiyel A Cutshaw, Maria Eugenia Guicciardi, Takashi Kitagataya, Kirsta E Olson, Kevin D Pavelko, William...> ;Scientific Reports. 2024 Jan 25
• Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort.
  Emiloju, O., Yin, J., Koubek, E., Reid, J., Borad, M., Lou, Y., Seetharam, M., Edelman, M., Sausville, E., Jiang, Y., Kaseb, A., Posey, J., Davis, S., Gores, G., Rober...> ;Investigational New Drugs. 2024 Feb 1
• 1 citations
  Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysis.
  Shah, A., Jones, M., Callaghan, G., Fairlie, T., Ma, X., Culver, E., Stuart, K., De Cruz, P., O'Beirne, J., Tabibian, J., Dignass, A., Canbay, A., Holtmann, G., Gores, G.> ;Hepatology Communications. 2024 Jan 1
• Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals.
  Harmeet Malhi, Robert S Brown Jr, Joseph K Lim, Nancy Reau, Elliot B Tapper, Carmen Chak-Lui Wong, Gregory J Gores> ;Liver Transplantation. 2023 Dec 1
• Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals.
  Brown, R., Wong, C., Malhi, H., Lim, J., Reau, N., Tapper, E., Gores, G.> ;Clinical Liver Disease. 2023 Dec 1
• 1 citations
  Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals.
  Harmeet Malhi, Robert S Brown Jr, Joseph K Lim, Nancy Reau, Elliot B Tapper, Carmen Chak-Lui Wong, Gregory J Gores> ;Hepatology. 2023 Dec 1
• Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals.
  Harmeet Malhi, Robert S Brown Jr, Joseph K Lim, Nancy Reau, Elliot B Tapper, Carmen Chak-Lui Wong, Gregory J Gores> ;Hepatology Communications. 2023 Nov 1
• 3 citations
  Fibroblasts in liver cancer: functions and therapeutic translation.
  Silvia Affo, Aveline Filliol, Gregory J Gores, Robert F Schwabe> ;The Lancet. Gastroenterology & Hepatology. 2023 Aug 1
• Rho-associated protein kinase 1 inhibition in hepatocytes attenuates nonalcoholic steatohepatitis.
  Ester Dohnalkova, Rachel L Bayer, Qianqian Guo, Adebowale O Bamidele, Hyun Se Kim Lee, Lucía Valenzuela-Pérez, Anuradha Krishnan, Kevin D Pavelko, Nicolas E S Guisot, ...> ;Hepatology Communications. 2023 Jun 1
• 19 citations
  Cholangiocarcinoma - novel biological insights and therapeutic strategies.
  Sumera I Ilyas, Silvia Affo, Lipika Goyal, Angela Lamarca, Gonzalo Sapisochin, Ju Dong Yang, Gregory J Gores> ;Nature Reviews. Clinical Oncology. 2023 Jul 1
• 1 citations
  CS-iCCA, A New Clinically Based Staging System for Intrahepatic Cholangiocarcinoma: Establishment and External Validation.
  Maria E Lozada, Ning Zhang, Weidong Jin, Nicha Wongjarupong, Ju Dong Yang, Molly M Voss, Kritika Prasai, Dominic O Amakye, William S Harmsen, Sushant Chaudhary, Oliver...> ;The American Journal of Gastroenterology. 2023 Dec 1
• 1 citations
  The Epigenetic Reader, Bromodomain Containing 2, Mediates Cholangiocyte Senescence via Interaction With ETS Proto-Oncogene 1.
  Jeong-Han Kang, Patrick L Splinter, Christy E Trussoni, Nicholas E Pirius, Gregory J Gores, Nicholas F LaRusso, Steven P O'Hara> ;Gastroenterology. 2023 Jul 1
• 1 citations
  Transcriptomic landscapes of effective and failed liver regeneration in humans.
  Patrick Starlinger, Laura Brunnthaler, Chantal McCabe, David Pereyra, Jonas Santol, Jessica Steadman, Matthias Hackl, Susanna Skalicky, Hubert Hackl, Raphael Gronauer,...> ;JHEP Reports. 2023 Apr 1
• 8 citations
  Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance.
  Diego F Calvisi, Luke Boulter, Javier Vaquero, Anna Saborowski, Luca Fabris, Pedro M Rodrigues, Cédric Coulouarn, Rui E Castro, Oreste Segatto, Chiara Raggi, Luc J W v...> ;Nature Reviews. Gastroenterology & Hepatology. 2023 Jul 1
• 1 citations
  Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States.
  Amro M Abdelrahman, Jun Yin, Roberto Alva-Ruiz, Jennifer A Yonkus, Jennifer L Leiting, Isaac T Lynch, Alessandro Fogliati, Nellie A Campbell, Danielle M Carlson, Lewis...> ;Cancers. 2023 Jan 30
• 1 citations
  Environmental chemicals and endogenous metabolites in bile of USA and Norway patients with primary sclerosing cholangitis.
  Caroline W Grant, Brian D Juran, Ahmad H Ali, Erik M Schlicht, Jackie K Bianchi, Xin Hu, Yongliang Liang, Zachery Jarrell, Ken H Liu, Young-Mi Go, Dean P Jones, Dougla...> ;Exposome. 2023 Jan 1
• 3 citations
  Algebraic topology-based machine learning using MRI predicts outcomes in primary sclerosing cholangitis.
  Yashbir Singh, William A Jons, John E Eaton, Mette Vesterhus, Tom Karlsen, Ida Bjoerk, Andreas Abildgaard, Kristin Kaasen Jorgensen, Trine Folseraas, Derek Little, Ali...> ;European Radiology Experimental. 2022 Nov 18
• 24 citations
  Liver Transplantation as a New Standard of Care in Patients With Perihilar Cholangiocarcinoma? Results From an International Benchmark Study.
  Breuer, E., Mueller, M., Doyle, M., Yang, L., Darwish Murad, S., Anwar, I., Merani, S., Limkemann, A., Jeddou, H., Kim, S., López-López, V., Nassar, A., Hoogwater, F.,...> ;Annals of Surgery. 2022 Nov 1
• 3 citations
  Disparities in curative treatments and outcomes for early stage intrahepatic cholangiocarcinoma in the United States.
  Yi-Te Lee, Amit G Singal, Marie Lauzon, Vatche G Agopian, Michael Luu, Mazen Noureddin, Tsuyoshi Todo, Irene K Kim, Marc L Friedman, Kambiz Kosari, Nicholas N Nissen, ...> ;Cancer. 2022 Oct 1
• 4 citations
  LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma.
  Caitlin B Conboy, Jennifer A Yonkus, EeeLN H Buckarma, Dong-Gi Mun, Nathan W Werneburg, Ryan D Watkins, Roberto Alva-Ruiz, Jennifer L Tomlinson, Yi Guo, Juan Wang, Dan...> ;Journal of Hepatology. 2023 Jan 1
• 9 citations
  Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination.
  Freddy Caldera, Francis A Farraye, Brian M Necela, Davitte Cogen, Sumona Saha, Arnold Wald, Nader D Daoud, Kelly Chun, Ian Grimes, Megan Lutz, Sean R Van Helden, Melan...> ;Inflammatory Bowel Diseases. 2023 Aug 1
• Join now to see all

Journal Articles

• Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances  
  Mario Strazzabosco, Florin M Selaru, Gregory J Gores, Xin Wei Wang, Hepatology
• Hepatocellular carcinoma: Clinical frontiers and perspectives  
  Bruix J, Gores GJ, Mazzaferro V, Gut, 1/1/2014
• Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation  
  Li J, Razumilava N, Gores GJ, Walters S, Mizuochi T, Mourya R, Bessho K, Wang YH, Glaser SS, Shivakumar P, Bezerra JA, J Clin Invest, 1/1/2014
• Gall bladder polyps in primary sclerosing cholangitis: Adhere to the guidelines  
  Gores G , Lindor KD, Razumilava N, Hepatology, 1/1/2012
• Reply  
  Breuhahn K, Gores G , Schirmacher P, Hepatology, 8/1/2011
• A klotho beta variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea  
  Wong BS, Camilleri M, Carlson PJ, Guicciardi ME, Burton D, McKinzie S, Rao AS, Zinsmeister AR, Gores GJ, Gastroenterology, 1/1/2011
• Practical management of hepatocellular carcinoma  
  Gores GJ, Gut and Liver, 1/1/2011
• Liver transplantation for non-hepatocellular carcinoma malignancies  
  Gores GJ, Heimbach JK, Rosen CB, Liver Transpl, 10/1/2010
• Reply: Diagnostic Utility of Chromosome 17 and p16 Abnormalities in Fluorescence In Situ Hybridization Tests in Primary Sclerosing Cholangitis  
  Bangarulingam SY, Bjornsson E, Enders F, Fritcher EG, Gores G , Halling KC, Lindor KD, Hepatology, 5/1/2010
• Obatoclax triggers bax mediated apoptosis in cholangiocarcinoma cells  
  Smoot R, Blechacz B, Bronk S, Werneburg N, Sirica A, Gores G, J Surg Res, 2/1/2010
• Current Opinion in Gastroenterology: Editorial introductions  
  Rockey D, Gores GJ, Curr Opin Gastroenterol, 1/1/2010
• Report of the Multisociety Task Force on GI Training  
  Friedman LS, Gores GJ, Vargo JJ, Brandt LJ, Katz PO, Stolar MH, Elta GH, Kuemmerle JF, Fitz JG, Pardi DS, Am J Gastroenterol, 11/1/2009
• Re: design and endpoints of clinical trials in hepatocellular carcinoma  
  Llovet JM, Gores GJ, J Natl Cancer Inst, 11/1/2008
• Editorial introductions  
  Pratt DS, Gores GJ, Curr Opin Gastroenterol, 1/1/2008
• Current status of liver transplantation for hilar cholangiocarcinoma  
  Rosen CB, Heimbach JK, Gores GJ, Current Opinion in Organ Transplantation, 6/1/2007
• Pathogenesis of liver injury  
  Gores GJ, Semin Liver Dis, 1/1/2007
• Death by association: BH3 domain-only proteins and liver injury  
  Baskin-Bey ES, Gores GJ, Am J Physiol Gastrointest Liver Physiol, 12/1/2005
• Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders  
  Ghobrial IM, Habermann TM, Maurer MJ, Geyer SM, Ristow KM, Larson TS, Walker RC, Ansell SM, Macon WR, Gores GG , Stegall MD, McGregor CG, J Clin Oncol, 10/1/2005
• The death receptor TRAIL in cancer cell apoptosis  
  Ishimura N, Gores GJ, Ann. Cancer Res Ther, 1/1/2005
• Idiopathic benign biliary strictures in surgically resected patients with presumed cholangiocarcinoma  
  Baskin-Bey ES, Devarbhavi HC, Nagorney DM, Farnell MB, Donohue JH, Sanderson SO, Stadheim LM, Gores GJ, HPB, 1/1/2005
• Cholangiocarcinoma: Pathogenesis, diagnosis, and management - Foreword  
  Gores GJ, Semin Liver Dis, 5/1/2004
• Differential gene expression patterns in HCV-infected allografts during acute cellular rejection  
  Sreekumar R, Wiessner RH, Gores GJ, Rosen CB, Charlton MR, Liver Transpl, 1/1/2003
• The role of cell-based bioartificial liver therapy in the treatment of fulminant hepatic failure  
  Nyberg SL, Matsushita T, Gores GJ, Hay JE, Wiesner RH, Pineda AA, Gastineau DA, Moore SB, Plevak DJ, Wijdicks EF, Piepgras DG, Platt JL, Rosen CB, Graft, 10/1/2002
• Cholangiocarcinoma  
  Torok N, Gores GJ, Semin Gastrointest, 4/1/2001
• Seminars in liver disease: foreword  
  Lindor KD, Gores GJ, Semin Liver Dis, 1/1/2001
• Join now to see all

Books/Book Chapters

• Shackelford's surgery of the alimentary tract. 
  Chapter: Primary sclerosing cholangitis. 
  Page 1405 - 1416Lazaridis KN, Gores GJEditors: Yeo CJ.Saunders Elsevier, Philadelphia, PAEdition 7th,2013
• Medical care of the liver transplant patient. 
  Chapter: Cholangiocarcinoma. 
  Page 133 - 144Masuoka HC, Gores GJ, Rosen CBEditors: Clavien PA; Trotter JF; Mullhaupt B.Wiley-Blackwell, Chichester; HobokenEdition 4th,2012
• Textbook of clinical gastroenterology and hepatology. 
  Chapter: Cholangiocarcinoma. 
  Page 580 - 585Lazaridis KN, Gores GJEditors: Hawkey CJ; et al.Wiley-Blackwell, Chichester; MaldenEdition 2nd,2012
• Zakim and Boyer's hepatology: a textbook of liver disease. 
  Chapter: Cholangiocarcinoma. 
  Page 1032 - 1044Lazaridis KN, Gores GJEditors: Boyer TD; Manns MP; Sanyal AJ.Saunders Elsevier, Philadelphia, PAEdition 6th,2012
• Surgery of the Liver Biliary Tract, and Pancreas 
  Chapter: Liver transplantation for cholangiocarcinoma and other neoplastic diseases. 
  Burns JM, Rosen CB, Heimbach JK, Gores GJEdition 5th,2012
• Schiff's diseases of the liver. 
  Chapter: Mechanisms of liver injury. 
  Page 216 - 231Malhi H, Gores GJ2011
• Molecular pathology of liver diseases. Molecular Pathology Library Series. 
  Chapter: Liver cell death. 
  Page 373 - 387Malhi H, Gores GJEditors: Monga SPS.Springer, New York2011
• Signaling pathways in liver diseases. 
  Chapter: Fas/FasL. 
  Page 179 - 188Guicciardi ME, Gores GJ.Editors: Dufour JF; Clavien PA.Springer, New YorkEdition 2nd,2010
• Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management. 
  Chapter: Tumors of the bile ducts, gallbladder, and ampulla. 
  Page 1171 - 1184Blechacz B, Gores GJEditors: Feldman M; Friedman LS; Brandt LJ.Saunders Elsevier, Philadelphia, PAEdition 9th,2010
• Textbook of gastroenterology. Volume 2 
  Chapter: Hepatocellular carcinoma. 
  Page 2386 - 2411Roberts LR, Gores GJEditors: Yamada T, et al.Wiley Blackwell Publishing, Chichester; HobokenEdition 5th,2009
• Schiff's diseases of the liver. 
  Chapter: of liver injury. 
  Page 313 - 328Malhi H, Gores GJEditors: Schiff ER, Sorrell MF, Maddrey WC.Lippincott Williams & Wilkins, Philadelphia, PAEdition 10th,2007
• Shackelford's surgery of the alimentary tract. Volume 2 
  Chapter: Primary sclerosing cholangitis. 
  Page 1560 - 1572Lazaridis KN, Gores GJEditors: Yeo CJ.Saunders, Philadelphia, PAEdition 6th,2007
• Cell death during HIV infection. 
  Chapter: Regulation of apoptosis. 
  Page 21 - 33Guicciardi ME, Gores GJEditors: Badley AD.CRC/ Taylor & Francis, Boca Raton2006
• Fas signaling. 
  Chapter: FasL and Fas in liver homeostasis and hepatic injuries. 
  Page 103 - 117Guicciardi ME, Gores GJEditors: Wajant H.Landes Bioscience/ Eurekah.com, Georgetown2006
• Mayo Clinic gastroenterology and hepatology board review. 
  Chapter: Liver mass lesions. 
  Page 281 - 288Gores GJEditors: Hauser SC.Mayo Clinic Scientific Press, Rochester, MNEdition 2nd,2006
• Therapy of digestive disorders. 
  Chapter: Cholangiocarcinoma and other biliary tumors. 
  Page 459 - 456Grambihler A, Gores GJEditors: Wolfe MM, et al.Saunders Elsevier, Philadelphia, PAEdition 2nd,2006
• Oncology: an evidence-based approach. 
  Chapter: Cancer of the liver and bile ducts. 
  Page 745 - 763Kendrick ML, Grambihler A, Gores GJ, Alberts S, Nagorney DMEditors: Chang AE, et al.Springer, New York2006
• Apoptosis 2005. 
  Chapter: The lysolsomal pathway of apoptosis. 
  Page 57 - 76Guicciardi ME, Gores GJEditors: Scovassi AI.Research Signpost, Kerala2005
• Signaling pathways in liver diseases. 
  Chapter: The Fas/FasL signaling pathway. 
  Page 129 - 138Guicciardi ME, Gores GJEditors: Dufour JF, Clavien PA.Springer, Berlin2005
• Clinical gastroenterology and hepatology. 
  Chapter: Cholangiocarcinoma. 
  Page 569 - 573Lazaridis KN, Gores GJ.Editors: Weinstein WM, Hawkey CJ, Bosch J.Elsevier Mosby, Edinburgh2005
• Advanced therapy in gastroenterology and liver disease. 
  Chapter: Primary sclerosing cholangitis and cholangiocarcinoma. 
  Page 715 - 719Angulo P, Gores GJEditors: Bayless TM, Diehl AM.CRC/ Taylor & Francis, HamiltonEdition 5th,2005
• Molecular pathogenesis of cholestasis. 
  Chapter: Bile acid-mediated apoptosis in cholestasis. 
  Page 126 - 134Higuchi H, Gores GJEditors: Trauner M, Jansen PLM.Landes Bioscience/ Eurekah.com, Georgetown2004
• The pathophysiology of biliary epithelia. 
  Chapter: Apoptosis of biliary epithelial cells. 
  Page 219 - 226Torok NJ, Gores GJEditors: Alpini G, et al.Landes Bioscience/ Eurekah.com, Georgetown2004
• Encyclopedia of gastroenterology. Vol. 2 
  Chapter: Liver abscess. 
  Page 507 - 509Torok NJ, Gores GJEditors: Johnson LR.Elsevier Academic Press, Amsterdam2004
• Essentials of apoptosis: a guide for basic and clinical research. 
  Chapter: The death receptor family and the extrinsic pathway. 
  Page 67 - 84Guicciardi ME, Gores GJEditors: Yin XM, Dong Z.Humana Press, Totowa, NJ2003
• Join now to see all

Abstracts/Posters

• Bloodstream infections (bsi) in patients undergoing liver transplantation (lt) for hilar cholangiocarcinoma (cca).
  Ramanan P, Cummins N, Wilhelm M, Heimbach J, Dierkhising R, Kremers W, Rosen C, Gores G , Razonable R, Transplantation, 7/1/2014
• Intra-abdominal infections in patients undergoing liver transplantation (lt) for hilar cholangiocarcinoma (cca).
  Ramanan P, Cummins N, Wilhelm M, Heimbach J, Dierkhising R, Kremers W, Rosen C, Gores G , Razonable R, Transplantation, 7/1/2014
• Risk factors for infections in patients undergoing liver transplantation (lt) for hilar cholangiocarcinoma (cca).
  Ramanan P, Cummins N, Wilhelm M, Heimbach J, Dierkhising R, Kremers W, Rosen C, Gores G , Razonable R, Transplantation, 7/1/2014
• Caspase activation as a target for alcohol induced hepatic inflammation.
  Verma VK, Kamath PS, Gores GJ, Shah VH, Alcohol Clin Exp Res, 6/1/2014
• Bloodstream infections (bsi) in patients undergoing liver transplantation (lt) for hilar cholangiocarcinoma (cca).
  Ramanan P, Cummins N, Wilhelm M, Heimbach J, Dierkhising R, Kremers W, Rosen C, Gores G , Razonable R, Am J Transplant, 6/1/2014
• Intra-abdominal infections in patients undergoing liver transplantation (lt) for hilar cholangiocarcinoma (cca).
  Ramanan P, Cummins N, Wilhelm M, Heimbach J, Dierkhising R, Kremers W, Rosen C, Gores G , Razonable R, Am J Transplant, 6/1/2014
• Risk factors for infections in patients undergoing liver transplantation (lt) for hilar cholangiocarcinoma (cca).
  Ramanan P, Cummins N, Wilhelm M, Heimbach J, Dierkhising R, Kremers W, Rosen C, Gores G , Razonable R, Am J Transplant, 6/1/2014
• The development of a tailored pancreatobiliary fluorescence in situ hybridization (fish) assay to improve detection of malignancy in pancreatobiliary brushings.
  Barr Fritcher EG, Kipp BR, Voss JS, Brankley SM, Keeney ME, Campion MB, Pestova EV, Sokolova IA, Song M, Roberts LR, Gores G , Clayton AC, Halling KC, J Mol Diagn, 11/1/2013
• Ring-domain dependent degradation of ciap-1 contributes to hepatocyte lipoapoptosis.
  Akazawa Y, Guicciardi ME, Bronk S, Werneburg N, Nakao K, Charlton MR, Gores GJ, Hepatology, 10/1/2013
• Presence of portal vein encasement predicts efficacy of radiation therapy in the liver transplantation for perihilar cholangiocarcinoma protocol.
  Bhat M, Hathcock M, Kremers WK, Murad SD, Martenson J, Alberts S, Rosen CB, Gores GJ, Heimbach J, Hepatology, 10/1/2013
• Validation of immunohistochemistry-based classification of hepatic adenomas: different subtype distribution in a large US experience.
  Dhanasekaran R, Kang YN, Smoot R, Moser CD, Gores GJ, Wu TT, Mounajjed T, Roberts LR, Hepatology, 10/1/2013
• Serum immunoglobulin g4 levels in primary sclerosing cholangitis.
  Imam M, Lindor KD, Gores GJ, LaRusso NF, Chari S, Lazaridis K, Talwalkar JA, Hepatology, 10/1/2013
• Novel genetic model of cholangiocarcinoma in mice.
  Razumilava N, Yamada D, Bronk S, Li J, Bezerra JA, Chen X, Gores GJ, Hepatology, 10/1/2013
• Pdgf-bb induces apoptotic priming of cancer-associated fibroblasts in cholangiocarcinoma.
  Rizvi S, Mertens JC, Bronk SF, Werneburg NW, Dai HM, Roberts LR, Kaufmann SH, Gores GJ, Hepatology, 10/1/2013
• Canonical tgf-beta signaling drives tumor-progression via jak/stat3-signaling in advanced hcc.
  Rojas A, Cromheecke J, Xiao LC, Lee MH, Hung MC, Gores GJ, Blechacz B, Hepatology, 10/1/2013
• Long term patient and graft-related outcomes after liver transplantation for primary sclerosing cholangitis.
  Singh S, Talwalkar JA, Hay JE, Poterucha JJ, Gores GJ, Charlton MR, Rosen CB, Heimbach J, Wiesner RH, Hepatology, 10/1/2013
• Impact of highly effective antiviral therapy on the burden of hepatocellular carcinoma in hepatitis c cirrhosis.
  Kim WR, Congley SE, Roberts LR, Gores GJ, J Hepatol, 4/1/2013
• Hedgehog signaling contributes to chemotaxis in cholangiocarcinoma cells.
  Razumilava N, Smoot RL, Mertens JC, Gradilone SA, Bronk SF, Sirica AE, Gores GJ, J Hepatol, 4/1/2013
• Outcome of transplant fallout patients with unresectable cholangiocarcinoma.
  Sio TT, Martenson JA, Haddock MG, Gores GJ, Alberts SR, Heimbach JK, Rosen CB, Int J Radiat Oncol Biol Phys, 11/1/2012
• Proctocolectomy is associated with development of cholangiocarcinoma among patients with primary sclerosing cholangitis and ulcerative colitis.
  Lammert C, Tabibian JH, Adebajo CO, Imam M, Talwalkar J, Gores GJ, Hepatology, 10/1/2012
• Therapeutic targeting of cancer-associated fibroblasts in cholangiocarcinoma.
  Mertens JC, Fingas CD, Christensen JD, Kakisaka K, Smoot R, Bronk SF, Mott JL, Gustafson MP, Dietz AB, Roberts LR, Sirica AE, Gores GJ, Hepatology, 10/1/2012
• An autocrine requirement for hedgehog signaling in cholangiocarcinogenesis.
  Razumilava N, Smoot R, Mertens JC, Bronk SF, Sirica AE, Gores GJ, Hepatology, 10/1/2012
• The impact of multiple tace treatments on hcc for patients awaiting liver transplantation.
  Terzi E, Kim WR, Sanchez W, Charlton M, Gores GJ, Heimbach J, Hepatology, 10/1/2012
• IDH1 and IDH2 mutations detected by pyrosequencing in cholangiocarcinoma.
  Voss JS, Kerr SE, Barr Fritcher EG, Highsmith WE, Zhang J, Roberts LR, Gores GJ, Halling KC, Kipp BR, Lab Invest, 2/1/2012
• IDH1 and IDH2 mutations detected by pyrosequencing in cholangiocarcinoma.
  Voss JS, Kerr SE, Barr Fritcher EG, Highsmith WE, Zhang J, Roberts LR, Gores GJ, Halling KC, Kipp BR, Mod Pathol, 2/1/2012
• Join now to see all

Lectures

• PG Course 
  Boston, MA - 1/1/2010
• Monothematic Conference 
  Oslo, Norway - 1/1/2009
• Academic Skills Workshop 
  Phoenix, AZ - 1/1/2009
• Endpoints Conference on PBC 
  Atlanta, GA - 1/1/2008
• Transplant Hepatology 
  Chicago, IL - 1/1/2008
• Future Trends 
  Washington, DC - 1/1/2008
• Future Trends Workshop 
  Washington, DC - 1/1/2008
• Therapy in Liver Disease 
  Barcelona, Spain - 1/1/2007
• Liver Fibrosis Update 
  Essen, Germany - 1/1/2007
• Human Genome Sciences 
  Gaithersburg, MD - 1/1/2007
• CAQ Board Review Course 
  Chicago, IL - 1/1/2006
• Fibrosis 
  Warrington, VA - 1/1/2006
• Therapy in Liver Diseases 
  Rome, Italy - 1/1/2003
• Celera 
  San Francisco, CA - 1/1/2003
• Experimental Biology 
  Orlando, FL - 1/1/2001
• Liver Transplantation 
  Dallas, TX - 1/1/2000
• Hepatology 2000 
  Munich, Germany - 1/1/2000
• Hepatoxicity 
  1/1/2000
• Hepatocellular Carcinoma 
  St. Louis, MO - 1/1/1998
• Cell Biology of Hypoxia 
  Gaithersburg, MD - 1/1/1996
• Bile Acids and the Future 
  Desert Springs, CA - 1/1/1993
• Study of Acute Hepatic Failure 
  Tokyo, Japan - 1/1/1992
• Join now to see all

Other

• Cell Death: Suicide vs. Murder. Postgraduate Course of the American Association for the Study of Liver Diseases. 
  Gores GJ, SLACK/SPN Interactive
  1/1/1997
• Hot Topics in Gastroenterology: Mass in the liver. 
  Gores GJ, Prime Practive: A CD-ROM series for Primary Care Practitioners, Vol. 2, No. 2
  1/1/1996
• Neoplastic cholangiopathies. 1996 Postgraduate Course of the Ameican Association for the Study of Liver Diseases. 
  Gores GJ, SLACK/SPN Interactive
  1/1/1996
• Apoptosis. The Best of the AASLD. 
  Gores GJ, Slack/Cd-Stat
• Join now to see all